Search
for
Sort by
Research 91–120 of 95
- Functional characterization and unraveling the structural determinants of novel steroid hydroxylase CYP154C7 from Streptomyces sp. PAMC26508
- Steroid Cell Tumor Without Virilization
- Mechanisms of Action of Dehydroepiandrosterone
- The Role of Heat Shock Proteins in the Pathogenesis of Polycystic Ovarian Syndrome: A Review of the Literature
- Genomic and Transcriptomic Characterization of Atypical Recurrent Flank Alopecia in the Cesky Fousek
- Plasma androsterone/epiandrosterone sulfates as markers of 5α-reductase activity: Effect of finasteride in normal men
- N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Comparison of Clinical and Biochemical Markers of Hirsutism in Polycystic Ovary Syndrome – A Study from a Teaching Hospital in Sri Ramachandra Institute, Chennai, India
- Hirsutism and virilization
- Androgens in women
- Gender Differences in Production and Circulating Levels of Sex Hormones and Their Impact on Aging Skin
- Diagnosis of hyperandrogenism: Biochemical criteria
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Quantitative analysis of 34 sex (pro)hormones, conjugates and bioactive oxidation products thereof in human plasma by GC- and LC-MS/MS and systematic investigation of overestimations of analyte concentrations not accounted for by method validation
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Hormone therapy in acne
- New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- First case of V281+I172N/V281L CYP21A2 genotype associated with congenital adrenal hyperplasia form. A case report from South Italy
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- Hormonal acne: leading to a paradigm shift in the management of acne
- Is dehydroepiandrosterone a hormone?
- Hormonal Therapy for Acne
- ANDROGENETIC ALOPECIA
- MENSTRUAL DISORDERS IN ADOLESCENTS
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007